Substituted 5,7-diphenyl-pyrrolo[2,3 d ]pyrimidines: potent inhibitors of the tyrosine kinase c-Src
摘要:
5,7-Diphenyl-pyrrolol[2,3d]pyrimidines represent a new class of highly potent inhibitors of the tyrosine kinase c-Src (IC50 < 50 nM) with specificity against a panel of different tyrosine kinases. The substitution pattern on the two phenyl rings determines potency and specificity and provides a means to modulate cellular activity. (C) 2000 Elsevier Science Ltd. All rights reserved.
Substituted 5,7-diphenyl-pyrrolo[2,3 d ]pyrimidines: potent inhibitors of the tyrosine kinase c-Src
摘要:
5,7-Diphenyl-pyrrolol[2,3d]pyrimidines represent a new class of highly potent inhibitors of the tyrosine kinase c-Src (IC50 < 50 nM) with specificity against a panel of different tyrosine kinases. The substitution pattern on the two phenyl rings determines potency and specificity and provides a means to modulate cellular activity. (C) 2000 Elsevier Science Ltd. All rights reserved.
[EN] PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE<br/>[FR] PYRROLO[2,3-d]PYRIMIDINES ET LEUR UTILISATION
申请人:NOVARTIS AG
公开号:WO1996010028A1
公开(公告)日:1996-04-04
(EN) Pyrrolo[2,3-d]pyrimidines of formula (I) in which R1, R2 and R3 are as defined in the description, have useful pharmaceutical properties and are particularly effective as inhibitors of the protein tyrosine kinase pp60c-src. They are prepared in a manner known per se.(FR) Pyrrolo[2,3-d]pyrimidines de formule (I) dans laquelle R1, R2 et R3 sont tels que définis dans la description. Ces composés possèdent des propriétés pharmacologiques utiles; ils sont notamment efficaces en tant qu'inhibiteurs de la tyrosine kinase pp60c-src et sont préparés d'une manière connue en soi.
Substituted 5,7-diphenyl-pyrrolo[2,3 d ]pyrimidines: potent inhibitors of the tyrosine kinase c-Src
作者:Martin Missbach、Eva Altmann、Leo Widler、Mira Šuša、Elisabeth Buchdunger、Helmut Mett、Thomas Meyer、Jonathan Green
DOI:10.1016/s0960-894x(00)00131-1
日期:2000.5
5,7-Diphenyl-pyrrolol[2,3d]pyrimidines represent a new class of highly potent inhibitors of the tyrosine kinase c-Src (IC50 < 50 nM) with specificity against a panel of different tyrosine kinases. The substitution pattern on the two phenyl rings determines potency and specificity and provides a means to modulate cellular activity. (C) 2000 Elsevier Science Ltd. All rights reserved.